Insider buying last 90 days
No open-market insider purchases were filed for THC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Tenet Healthcare shares have moved higher this week after the company reported Q3 2026 results of $5,631 million in sales and $1,000 million in net income, prompting raised full-year 2026 guidance for net operating revenues of $22,050 million to $22,450 million and diluted EPS of $35.82 to $37.08. The report drew a string of positive commentary, with some coverage noting the stock trades at roughly 7.9x earnings versus a sector average of 25.8x, and analyst actions followed, including Barclays reiterating an Overweight rating and raising its price target to $297 from $271, and Argus lifting its target to $293.00. Shares also moved with broader healthcare peers after election results confirmed Democratic majorities in the House and Senate.
THC closed at $289.00, up 2% on the day, and sits above both its 50-day average of $265.80 and 200-day average of $222.84, with the 50-day above the 200-day. The GekkoIndex reads 48.9, placing it in the Neutral zone, down 5.9 points over the past five readings. Price sits 3.4% below Gekko Fair Value of $299.32.
The next earnings report is scheduled for 10 February 2027, 92 days out, beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 3.8% gain over five years, rising in four of them. Analyst consensus stands at 13 buy, 2 hold, 0 sell ratings, with a consensus target of $304.14, about 5.2% above current levels.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Tenet Healthcare scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $286.03 is above the 50-day ($267.85) and 200-day ($224.83) averages, and the 50-day is above the 200-day.
See the chart52.8, Neutral
Reading 52.8 is in the Neutral zone.
See the GekkoIndex3.0% below
Price is within 5% of Gekko Fair Value (3% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 87 days
Next report Feb 10, 2027, 87 days away — outside a typical 20-trading-day hold.
See earnings+3.5% on average
From this point in the calendar, the next 20 trading days averaged +3.5% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Tenet Healthcare closed at $286.03 on Nov 13, 2026, +43.0% over the past year, inside a 52-week range of $157.58 to $301.44.
Use the left and right arrow keys to read daily values.
Put THC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Tenet Healthcare provides a wide range of medical services through hospitals and related clinical sites. Its acute care facilities cover core hospital functions such as surgery and recovery, radiology, respiratory therapy, laboratory work, and pharmacy services, along with intensive and coronary care units. The company also handles specialized treatment in areas like cardiovascular care, digestive disease, neurosciences, musculoskeletal conditions, and obstetrics, extending into advanced procedures including cardiothoracic and neurosurgery, organ transplants, trauma care, stroke treatment, and telemedicine.
Tenet organizes its work into three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Ambulatory Care side runs outpatient surgical centers, urgent care sites, imaging centers, and micro-hospitals, while Conifer supplies business process support to hospitals, health systems, physician practices, and employers, covering revenue cycle management, patient communication, and care outcome services.
Tenet Healthcare was founded in 1975 and is headquartered in Dallas, Texas. Its shares are listed on the NYSE under the ticker THC.
Tenet Healthcare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 52.8, in the Neutral zone, up 3.3 points over five sessions.
Up 3.3 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +2.5% | +10.9% | ||
| Accumulation | 170 | +1.2% | +5.4% | ||
| Neutral (current zone) | 446 | +1.1% | +2.9% | ||
| Distribution | 55 | +0.2% | +6.4% | ||
| Selling | 3 | Too few readings yet | |||
Average THC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Tenet Healthcare trades 3.0% below Gekko Fair Value of $295.02, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Tenet Healthcare shares are worth, recalculated every trading day.
$295.02
Gekko Fair Value, Nov 14, 2026
3.0% below fair value · About fair value
At the end of Aug 2026 the price was 7.4% below the estimate.
No open-market insider purchases were filed for Tenet Healthcare, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for THC in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in THC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Tenet Healthcare has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds THC.
Tenet Healthcare reports on Feb 10, 2027 (87 days away), and beat the EPS estimate in 8 of its last 8 reports.
Feb 10, 2027
87 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 23, 2026 | $6.12 est $4.26 | $5.63B est $5.43B | +19.4% |
| Apr 30, 2026 | $4.82 est $4.17 | $5.37B est $5.39B | +1.8% |
| Feb 11, 2026 | $4.70 est $4.07 | $5.53B est $5.47B | +20.3% |
| Oct 28, 2025 | $3.70 est $3.34 | $5.29B est $5.26B | −3.3% |
| Jul 22, 2025 | $4.02 est $2.87 | $5.27B est $5.16B | −9.4% |
| Apr 29, 2025 | $4.36 est $3.13 | $5.22B est $5.14B | +15.4% |
| Feb 12, 2025 | $3.44 est $2.83 | $5.07B est $5.17B | −3.8% |
| Oct 29, 2024 | $2.93 est $2.37 | $5.12B est $5.05B | +13.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Tenet Healthcare is $307.32, +7.4% from the last close, from 16 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 16 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | Mizuho Securities | $330 | +15.4% |
| Nov 10 | Goldman Sachs | $320 | +11.9% |
| Nov 5 | Bank of America Securities | — | — |
| Nov 4 | Barclays | $297 | +3.8% |
| Nov 3 | KeyBanc | $300 | +4.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Tenet Healthcare averaged +3.5% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.3% | 2 of 5 |
| Next 10 trading days | +2.2% | 3 of 5 |
| Next 15 trading days | +1.9% | 3 of 5 |
| Next 20 trading days | +3.5% | 3 of 5 |
| Next 30 trading days | +5.1% | 4 of 5 |
For scale, THC’s typical 20-trading-day move in either direction is about 8.3%.
Tenet Healthcare’s market cap is $22.76B, with a P/E ratio of 8.3 and revenue of $22.15B over the last twelve months.
Coverage of Tenet Healthcare this week reads positive: 4 positive, 2 neutral and 1 negative headlines.
Tenet Healthcare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| HCAHCA Healthcare | Neutral | 26.1% above |
| UHSUniversal Health Services | Neutral | 11.5% below |
| PACSPACS | Neutral | 6.5% below |
| CHEChemed | Neutral | 2.8% below |
| SGRYSurgery Partners | Distribution | 45.2% above |
| NHCNational HealthCare | Accumulation | 18.9% above |
A peer links to its own page where one exists.
Tenet Healthcare’s market cap is $22.76B at the Nov 13, 2026 close of $286.03, with 79.59M shares outstanding. The shares trade on a P/E ratio of 8.3.
The consensus analyst 12-month price target for Tenet Healthcare is $307.32, +7.4% from the last close. Of the 16 firms that rated the stock in the last 90 days, 14 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Tenet Healthcare is about fair value: the Nov 13, 2026 close of $286.03 is 3.0% below Gekko Fair Value of $295.02. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Tenet Healthcare is expected to report on Feb 10, 2027 (87 days away). Analysts expect earnings of $5.36 per share on revenue of $5.68B. Tenet Healthcare beat the earnings estimate in 8 of its last 8 reports, moving 10.8% on average across the report.
Tenet Healthcare’s 52-week high is $301.44 and its 52-week low is $157.58; it closed at $286.03 on Nov 13, 2026, +43.0% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.